Skip to main content
Top

Experimental Hematology & Oncology

2012 - 2024
Volumes
13
Issues
Chevron right icon
Issue 1/2024
Latest issue

About this journal

Experimental Hematology & Oncology publishes preclinical, basic, patient-oriented and translational research in all areas of hematology and oncology. The journal acts as an international platform for sharing laboratory findings and makes a deliberate effort to publish clinical trials with 'negative' results, as well as basic science studies with provocative findings. This peer-reviewed, open access journal offers impressive turnaround times with a time to first decision of less than 30 days.

Metadata
Title
Experimental Hematology & Oncology
Coverage
Volume 1/2012 - Volume 13/2024
Publisher
BioMed Central
Electronic ISSN
2162-3619
Journal ID
40164
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine